Brian Strem
Vorstandsvorsitzender bei KIORA PHARMACEUTICALS, INC.
Vermögen: 49 488 $ am 30.04.2024
Aktive Positionen von Brian Strem
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 26.07.2021 | - |
| Direktor/Vorstandsmitglied | 26.07.2021 | - | |
| Präsident | 26.07.2021 | - | |
| Comptroller/Controller/Auditor | 16.06.2022 | - | |
| Finanzdirektor/CFO | 16.06.2022 | - | |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Direktor/Vorstandsmitglied | 01.06.2015 | - |
| Finanzdirektor/CFO | - | - | |
| Gründer | - | - | |
| Unternehmenssekretär | - | - | |
Yellowbrick Bio LLC
 Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
| Gründer | 01.01.2020 | - | |
| Corporate Officer/Principal | - | - | |
| Bayon Therapeutics, Inc. | Direktor/Vorstandsmitglied | - | - |
| Gründer | - | - |
Karriereverlauf von Brian Strem
Ausbildung von Brian Strem
| Cornell University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Director/Board Member | 4 |
| Founder | 3 |
| Director of Finance/CFO | 2 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Okogen, Inc.
Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Commercial Services |
Yellowbrick Bio LLC
Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Health Technology |
| Bayon Therapeutics, Inc. |
- Börse
- Insiders
- Brian Strem
- Erfahrung
